Fully Automated Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Fusion via a Probabilistic Registration Metric

被引:10
|
作者
Sparks, Rachel [1 ,2 ]
Bloch, B. Nicolas [3 ]
Feleppa, Ernest [4 ]
Barratt, Dean [5 ]
Madabhushi, Anant [2 ]
机构
[1] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08855 USA
[2] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA
[3] Boston Univ, Boston Med Ctr, Dept Radiol, Boston, MA 02215 USA
[4] Lizzi Ctr Biomed Engn, Riverside Res, New York, NY 10001 USA
[5] UCL, Ctr Med Image Comp, London, England
基金
美国国家科学基金会;
关键词
MRI/TRUS DATA FUSION; GUIDED BIOPSY; CANCER-DETECTION; IMAGES; MRI; SEGMENTATION; INHOMOGENEITY; BRACHYTHERAPY; SPECTROSCOPY; STATISTICS;
D O I
10.1117/12.2007610
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this work, we present a novel, automated, registration method to fuse magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS) images of the prostate. Our methodology consists of: (1) delineating the prostate on MRI, (2) building a probabilistic model of prostate location on TRUS, and (3) aligning the MRI prostate segmentation to the TRUS probabilistic model. TRUS-guided needle biopsy is the current gold standard for prostate cancer (CaP) diagnosis. Up to 40% of CaP lesions appear isoechoic on TRUS, hence TRUS-guided biopsy cannot reliably target CaP lesions and is associated with a high false negative rate. MRI is better able to distinguish CaP from benign prostatic tissue, but requires special equipment and training. MRI-TRUS fusion, whereby MRI is acquired pre-operatively and aligned to TRUS during the biopsy procedure, allows for information from both modalities to be used to help guide the biopsy. The use of MRI and TRUS in combination to guide biopsy at least doubles the yield of positive biopsies. Previous work on MRI-TRUS fusion has involved aligning manually determined fiducials or prostate surfaces to achieve image registration. The accuracy of these methods is dependent on the reader's ability to determine fiducials or prostate surfaces with minimal error, which is a difficult and time-consuming task. Our novel, fully automated MRI-TRUS fusion method represents a significant advance over the current state-of-the-art because it does not require manual intervention after TRUS acquisition. All necessary preprocessing steps (i.e. delineation of the prostate on MRI) can be performed offline prior to the biopsy procedure. We evaluated our method on seven patient studies, with B-mode TRUS and a 1.5 T surface coil MRI. Our method has a root mean square error (RMSE) for expertly selected fiducials (consisting of the urethra, calcifications, and the centroids of CaP nodules) of 3.39 +/- 0.85 mm.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Multiattribute probabilistic prostate elastic registration (MAPPER): Application to fusion of ultrasound and magnetic resonance imaging
    Sparks, Rachel
    Bloch, B. Nicolas
    Feleppa, Ernest
    Barratt, Dean
    Moses, Daniel
    Ponsky, Lee
    Madabhushi, Anant
    MEDICAL PHYSICS, 2015, 42 (03) : 1153 - 1163
  • [2] Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of the Prostate-An Update
    Das, Chandan J.
    Razik, Abdul
    Sharma, Sanjay
    SEMINARS IN ROENTGENOLOGY, 2018, 53 (03) : 219 - 226
  • [3] Magnetic Resonance - Transrectal Ultrasound Fusion Guided Prostate Biopsy
    Argun, Omer Burak
    Obek, Can
    Kural, Ali Riza
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2016, 15 (02): : 76 - 79
  • [4] The Comparison of Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsies with Conventional Transrectal Biopsies in Prostate Cancer Detection
    Baba, Dursun
    Balik, Ahmet Yildirim
    Yuksel, Alpaslan
    Senoglu, Yusuf
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2021, 20 (04): : 210 - 214
  • [5] Magnetic Resonance Imaging Fusion Transrectal Ultrasound-guided Biopsy for Diagnosis of Prostate Cancer
    Wang, Hsin-Kai
    JOURNAL OF MEDICAL ULTRASOUND, 2021, 29 (02) : 75 - 76
  • [6] Visibility of prostate cancer on transrectal ultrasound during fusion with multiparametric magnetic resonance imaging for biopsy
    van de Ven, Wendy J. M.
    Sedelaar, J. P. Michiel
    van der Leest, Marloes M. G.
    Hulsbergen-van de Kaa, Christina A.
    Barentsz, Jelle O.
    Futterer, Jurgen J.
    Huisman, Henkjan J.
    CLINICAL IMAGING, 2016, 40 (04) : 745 - 750
  • [7] Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: a comparison with systematic transrectal ultrasound-guided prostate biopsy
    Silecchia, G.
    Falagario, U.
    Sanguedolce, F.
    Macarini, L.
    Autorino, R.
    Cormio, L.
    JOURNAL OF GERONTOLOGY AND GERIATRICS, 2018, 66 (04): : 200 - 204
  • [8] Magnetic Resonance Imaging/Ultrasound Fusion-guided Transperineal Versus Magnetic Resonance Imaging/Ultrasound Fusion-guided Transrectal Prostate Biopsy-A Systematic Review
    Rai, Bhavan Prasad
    Mayerhofer, Christoph
    Somani, Bhaskar Kumar
    Kallidonis, Panagiotis
    Nagele, Udo
    Tokas, Theodoros
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (06): : 904 - 913
  • [9] Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy Improves Cancer Detection Following Transrectal Ultrasound Biopsy and Correlates With Multiparametric Magnetic Resonance Imaging
    Pinto, Peter A.
    Chung, Paul H.
    Rastinehad, Ardeshir R.
    Baccala, Angelo A., Jr.
    Kruecker, Jochen
    Benjamin, Compton J.
    Xu, Sheng
    Yan, Pingkun
    Kadoury, Samuel
    Chua, Celene
    Locklin, Julia K.
    Turkbey, Baris
    Shih, Joanna H.
    Gates, Stacey P.
    Buckner, Carey
    Bratslavsky, Gennady
    Linehan, W. Marston
    Glossop, Neil D.
    Choyke, Peter L.
    Wood, Bradford J.
    JOURNAL OF UROLOGY, 2011, 186 (04): : 1281 - 1285
  • [10] Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: A prospective development study
    Valerio, Massimo
    Shah, Taimur Tariq
    Shah, Paras
    Mccartan, Neil
    Emberton, Mark
    Arya, Manit
    Ahmed, Hashim Uddin
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (04) : 150.e1 - 150.e7